NCT04452500View on ClinicalTrials.gov

Phase IIa Trial of a Selective Glucocorticoid Receptor Antagonist in the Treatment of Veterans With Posttraumatic Stress Disorder (PTSD) (Seven Study)

PHASE2RecruitingINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

October 15, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
PTSD
Interventions
DRUG

CORT108297

CORT108297- 180mg daily for 7 days

DRUG

Placebo

Placebo- 180mg daily for 7 days

Trial Locations (2)

35404

RECRUITING

Tuscaloosa VA Medical Center, Tuscaloosa, AL, Tuscaloosa

94121-1563

RECRUITING

San Francisco VA Medical Center, San Francisco, CA, San Francisco

All Listed Sponsors
lead

VA Office of Research and Development

FED